Dexcom Clarity is a reporting tool that can help people and clinicians review CGM patterns over time. The useful part is not a single graph, but the repeated pattern behind meals, sleep, exercise, illness, and medicine timing.
Quick summary
CGM reports can support better conversations, but they should not replace symptoms, meter confirmation when needed, or medical judgment.
Key takeaways
- Time in range, time below range, average glucose, variability, and daily patterns can be useful.
- One unusual day should not drive major treatment changes.
- Low-glucose patterns deserve careful review, especially with insulin or sulfonylureas.
- Data sharing should be intentional and privacy-aware.
What to review first
- How often lows are happening.
- Whether lows cluster overnight, after activity, or before meals.
- Whether highs follow certain meals or missed doses.
- Whether sensor gaps, compression lows, or app issues may affect the report.
- What changed during the report period.
Use reports carefully
CGM measures glucose in interstitial fluid, not directly in blood. Fingerstick confirmation may still be needed when symptoms do not match readings, when a device instructs you to confirm, or when readings would lead to a high-risk decision.
Bring notes with the report: illness, travel, new medicine, sensor changes, exercise, alcohol, missed meals, or steroid use. Context makes the data safer.
Practical takeaway
Use Dexcom Clarity as a pattern tool, not a blame tool. The best report is one that leads to safer questions.
Safety note
This article is not a substitute for medical care. Seek urgent care for severe low blood sugar, confusion, fainting, vomiting with high glucose or ketones, or symptoms that feel unsafe.
What to ask your care team
- Which pattern matters most?
- Do I need meter confirmation for certain situations?
- Should alert settings or medicine timing be reviewed?
Related reading
Source summary
- Dexcom Clarity, Dexcom. Product information. Accessed June 5, 2026. Source
- Diabetes Technology: Standards of Care in Diabetes 2026, American Diabetes Association. Clinical guideline. Accessed June 5, 2026. Source
- Continuous Glucose Monitoring, National Institute of Diabetes and Digestive and Kidney Diseases. Patient guidance. Accessed June 5, 2026. Source
- Blood Glucose Monitoring Devices, U.S. Food and Drug Administration. Device information. Accessed June 5, 2026. Source